(Q33603744)

28 July 2017

1 reference

title

Treatment of amyotrophic lateral sclerosis (English)

1 reference

amyotrophic lateral sclerosis

28 July 2017

main subject

0 references

author name string

Eisen A

series ordinal

1

1 reference

28 July 2017

Weber M

series ordinal

2

1 reference

28 July 2017

publication date

1 March 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

14

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

173-196

1 reference

(-)Deprenyl increases the life span as well as activities of superoxide dismutase and catalase but not of glutathione peroxidase in selective brain regions in Fischer rats

28 July 2017

cites work

1 reference

12 December 2020

Prevention of motoneuron death by adenovirus-mediated neurotrophic factors

1 reference

12 December 2020

Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis

1 reference

12 December 2020

Vitamin E and coronary heart disease: the European paradox

1 reference

12 December 2020

Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia.

1 reference

12 December 2020

Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease

1 reference

12 December 2020

Increased binding of 3H-L-deprenyl in spinal cords from patients with amyotrophic lateral sclerosis as demonstrated by autoradiography

1 reference

12 December 2020

Amyotrophic lateral sclerosis. An autoimmune disease?

1 reference

12 December 2020

Excitatory amino acid receptors, excitotoxicity, and the human nervous system.

1 reference

12 December 2020

Autoimmunity as an etiological factor in sporadic amyotrophic lateral sclerosis

1 reference

12 December 2020

Double blind cross over trial with deprenyl in amyotrophic lateral sclerosis

1 reference

12 December 2020

Non-NMDA receptors in motor neuron disease (MND): a quantitative autoradiographic study in spinal cord and motor cortex using [3H]CNQX and [3H]kainate

1 reference

12 December 2020

Clinical epidemiology of amyotrophic lateral sclerosis

1 reference

12 December 2020

1 reference

12 December 2020

Prevention of apoptotic motoneuron death in vitro by neurotrophins and muscle extract.

1 reference

12 December 2020

Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu,Zn superoxide dismutase

1 reference

12 December 2020

Grafting immortalized neurons to the CNS.

1 reference

12 December 2020

Regulation of apoptosis resistance and ontogeny of age-dependent diseases

1 reference

12 December 2020

Respiratory muscle rest using nasal BiPAP ventilation in patients with stable severe COPD

1 reference

12 December 2020

Insulin-like growth factor-1 receptors in human spinal cord: changes in amyotrophic lateral sclerosis

1 reference

12 December 2020

Deprenyl enhances neurite outgrowth in cultured rat spinal ventral horn neurons

1 reference

12 December 2020

Monoamine oxidase-B in motor cortex and spinal cord in amyotrophic lateral sclerosis studied by quantitative autoradiography.

1 reference

12 December 2020

Apoptosis in neurodegenerative disorders: potential for therapy by modifying gene transcription

1 reference

12 December 2020

High-dose dextromethorphan in amyotrophic lateral sclerosis: phase I safety and pharmacokinetic studies

1 reference

12 December 2020

Rising mortality from motoneuron disease in the USA, 1962-84.

1 reference

12 December 2020

Management of ALS: respiratory care

1 reference

12 December 2020

A clinical trial of verapamil in amyotrophic lateral sclerosis

1 reference

12 December 2020

Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis

1 reference

12 December 2020

Ciliary neurotrophic factor: Pharmacokinetics and acute-phase response in rat

1 reference

12 December 2020

Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure

1 reference

12 December 2020

The natural history of motoneuron loss in amyotrophic lateral sclerosis

1 reference

12 December 2020

Neurotrophin‐3 reverses experimental cisplatin‐induced peripheral sensory neuropathy

1 reference

12 December 2020

Lack of improvement with ceftriaxone in motoneuron disease

1 reference

12 December 2020

N-acetylcysteine depresses contractile function and inhibits fatigue of diaphragm in vitro

1 reference

12 December 2020

Dehydroepiandrosterone: Kinetics of Metabolism in Normal Men and Women*

1 reference

12 December 2020

Apoptosis in the Nervous System: Morphological Features, Methods, Pathology, and Prevention

1 reference

12 December 2020

Amyotrophic lateral sclerosis is a multifactorial disease

1 reference

12 December 2020

Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF.

1 reference

12 December 2020

The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis

1 reference

12 December 2020

Neurotrophic factor therapy for nervous system degenerative diseases

1 reference

12 December 2020

A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group

1 reference

12 December 2020

Use of gabapentin in pain management

1 reference

12 December 2020

N-acetylcysteine inhibits muscle fatigue in humans

1 reference

12 December 2020

Prospects for quantitative trait locus methodology in gerontology

1 reference

12 December 2020

Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria

1 reference

12 December 2020

An open-randomized clinical trial of selegiline in amyotrophic lateral sclerosis

1 reference

12 December 2020

Clinical trials of riluzole in patients with ALS. ALS/Riluzole Study Group-II.

1 reference

12 December 2020

Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole.

1 reference

12 December 2020

Telomerase, checkpoints and cancer

1 reference

12 December 2020

DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range.

1 reference

12 December 2020

Management of ALS: nutritional care

1 reference

12 December 2020

Scavenger effect of vitamin E and derivatives on free radicals generated by photoirradiated pheomelanin

1 reference

12 December 2020

Duration of amyotrophic lateral sclerosis is age dependent

1 reference

12 December 2020

El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases a

1 reference

12 December 2020

Potential of neural "stem-like" cells for gene therapy and repair of the degenerating central nervous system

1 reference

12 December 2020

3,4-diaminopyridine as a treatment for amyotrophic lateral sclerosis

1 reference

12 December 2020

Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline).

1 reference

12 December 2020

Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy

1 reference

12 December 2020

Selegiline is ineffective in a collaborative double-blind, placebo-controlled trial for treatment of amyotrophic lateral sclerosis

1 reference

12 December 2020

Neuroimmune mechanisms in Alzheimer disease pathogenesis

1 reference

12 December 2020

Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS Study Group. Western Amyotrophic Lateral Sclerosis Study Group

1 reference

12 December 2020

[Telomere DNA and telomerase of lymphoma-derived cell lines--telomere hypothesis for cell growth control]

1 reference

12 December 2020

Telomeres: beginning to understand the end.

1 reference

12 December 2020

Will ciliary neurotrophic factor slow progression of motor neuron disease?

1 reference

12 December 2020

Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiation

1 reference

12 December 2020

A rationale for monoamine oxidase inhibition as neuroprotective therapy for Parkinson's disease

1 reference

12 December 2020

Treatment of amyotrophic lateral sclerosis using a gene therapy approach

1 reference

12 December 2020

Distribution and levels of insulin-like growth factor (IGF-I and IGF-II) and insulin receptor binding sites in the spinal cords of amyotrophic lateral sclerosis (ALS) patients.

1 reference

12 December 2020

alpha-Tocopherol quinone level is remarkably low in the cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis

1 reference

12 December 2020

Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis

1 reference

12 December 2020

Riluzole for the treatment of amyotrophic lateral sclerosis--too soon to tell?

1 reference

12 December 2020

Role of neurotrophins in preventing glutamate induced neuronal cell death

1 reference

12 December 2020

Neurotrophic factors: two are better than one

1 reference

12 December 2020

A pilot trial of dextromethorphan in amyotrophic lateral sclerosis

1 reference

12 December 2020

The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease

1 reference

12 December 2020

Emerging perspectives on the mechanism of action of gabapentin

1 reference

12 December 2020

Multipotent neural progenitor or stem-like cells may be uniquely suited for therapy for some neurodegenerative conditions

1 reference

12 December 2020

Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse

1 reference

12 December 2020

Protection from oxidation enhances the survival of cultured mesencephalic neurons

1 reference

12 December 2020

Experimental rationale for the therapeutic use of neurotrophins in amyotrophic lateral sclerosis

1 reference

12 December 2020

Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis

1 reference

12 December 2020

Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons

1 reference

12 December 2020

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

12 December 2020

The effect of gabapentin on neuropathic pain

1 reference

12 December 2020

Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitution.

1 reference

12 December 2020

Tissue-specific targeting of retroviral vectors through ligand-receptor interactions

1 reference

12 December 2020

Gene transfer to the mammalian brain using neural stem cells: a focus on trophic factors, neuroregeneration, and cholinergic neuron systems

1 reference

12 December 2020

A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group

1 reference

12 December 2020

Physiological importance of dehydroepiandrosterone

1 reference

12 December 2020

Excitotoxicity hypothesis

1 reference

12 December 2020

Excitatory amino acids as a final common pathway for neurologic disorders.

1 reference

12 December 2020

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?: The Rotterdam Study

1 reference

12 December 2020

Sex steroids and 5-en-3 beta-hydroxysteroids in specific regions of the human brain and cranial nerves

1 reference

12 December 2020

Dehydroepiandrosterone and its sulfate enhance memory retention in mice

1 reference

12 December 2020

Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II

1 reference

12 December 2020

Applications of telomerase in urologic oncology

1 reference

12 December 2020

Calcium channels and neuromuscular disease

1 reference

12 December 2020

Apoptosis: clinical relevance and pharmacological manipulation

1 reference

12 December 2020

Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis

1 reference

12 December 2020

Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF

1 reference

12 December 2020

Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis

1 reference

12 December 2020

Infusion of neurosteroids into the nucleus basalis magnocellularis affects cognitive processes in the rat.

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

1 reference

12 December 2020

Riluzole, a novel antiglutamate, blocks GABA uptake by striatal synaptosomes

1 reference

12 December 2020

Steroids and their conjugates in the mammalian brain

1 reference

12 December 2020

Evidence for autoimmunity in amyotrophic lateral sclerosis

1 reference

12 December 2020

Dehydroepiandrosterone sulphate (DHEAS) concentrations and amyotrophic lateral sclerosis

1 reference

12 December 2020

Diet, antioxidant vitamins, oxidative stress and risk of coronary artery disease: the Peerzada Prospective Study.

1 reference

12 December 2020

Issues in clinical trial design I: Use of natural history controls. A protagonist view

1 reference

12 December 2020

Localization of neuronal and glial glutamate transporters

1 reference

12 December 2020

Molecular genetic basis of familial ALS.

1 reference

12 December 2020

BDNF prevents and reverses adult rat motor neuron degeneration and induces axonal outgrowth.

1 reference

12 December 2020

Branched-chain amino acids in the treatment of amyotrophic lateral sclerosis.

1 reference

12 December 2020

Improvement of patient with amyotrophic lateral sclerosis given ceftriaxone

1 reference

12 December 2020

Lou Gehrig and amyotrophic lateral sclerosis. Is vitamin E to be revisited?

1 reference

12 December 2020

Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro

1 reference

12 December 2020

Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action

1 reference

12 December 2020

Role of antioxidants in health maintenance

1 reference

12 December 2020

Controlled trial of nimodipine in amyotrophic lateral sclerosis

1 reference

12 December 2020

Late-onset selective neuronal damage in the rat spinal cord induced by continuous intrathecal administration of AMPA

1 reference

12 December 2020

Excitatory amino acids, free radicals and the pathogenesis of motor neuron disease

1 reference

12 December 2020

An effect of L-leucine and other essential amino acids on the structure and activity of glutamic dehydrogenase

1 reference

12 December 2020

Vitamin E. Neurochemistry and implications for neurodegeneration in Parkinson's disease

1 reference

12 December 2020

Metals and free radicals in neurodegeneration

1 reference

12 December 2020

Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease.

1 reference

12 December 2020

In vivo and ex vivo gene transfer to the brain

1 reference

12 December 2020

Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice

1 reference

12 December 2020

[Antioxidants and cardiovascular disorders--epidemiologic aspects. Should high risk patients receive supplementation?]

1 reference

12 December 2020

Neurosteroids: a new function in the brain

1 reference

12 December 2020

Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group

1 reference

12 December 2020

Failure of ceftriaxone for amyotrophic lateral sclerosis

1 reference

12 December 2020

Dextrorphan and levorphanol selectively block N-methyl-D-aspartate receptor-mediated neurotoxicity on cortical neurons

1 reference

12 December 2020

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

1 reference

12 December 2020

Fibroblast growth factors, proteins with a broad spectrum of biological activities.

1 reference

12 December 2020

Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex

1 reference

12 December 2020

[Failure of empirical treatment with ceftriaxone in motor neuron disease]

1 reference

12 December 2020

Differential effects of dextrorphan and levorphanol on the excitation of rat spinal neurons by amino acids.

1 reference

12 December 2020

A controlled trial of amino acid therapy in amyotrophic lateral sclerosis: I. Clinical, functional, and maximum isometric torque data

1 reference

12 December 2020

Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis

1 reference

12 December 2020

Protective effects of SR 57746A in central and peripheral models of neurodegenerative disorders in rodents and primates

1 reference

12 December 2020

Neurotrophic factors in the treatment of motor neuron disease and trauma

1 reference

12 December 2020

Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis

1 reference

12 December 2020

Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients

1 reference

12 December 2020

Anti-glutamate therapy in amyotrophic lateral sclerosis: a trial using lamotrigine.

1 reference

12 December 2020

Disruption of the CNTF gene results in motor neuron degeneration.

1 reference

12 December 2020

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

1 reference

12 December 2020

Can nimodipine affect progression of motor neuron disease? A double-blind pilot study

1 reference

12 December 2020

Telomere reduction and telomerase inactivation during neuronal cell differentiation

1 reference

12 December 2020

Branched-chain amino acids and amyotrophic lateral sclerosis: a treatment failure? The Italian ALS Study Group

1 reference

12 December 2020

Cu/Zn superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis

1 reference

12 December 2020

Nocturnal assisted ventilation using bilevel positive airway pressure: the effect of expiratory positive airway pressure.

1 reference

12 December 2020

Activation of glutamate dehydrogenase by leucine and its nonmetabolizable analogue in rat brain synaptosomes.

1 reference

12 December 2020

10.2165/00002512-199914030-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

1028314543

0 references

1 reference